Human antibodies against the polymorphic epithelial mucin in ovarian cancer patients recognise a novel sequence in the tandem repeat region

C. Petrarca, A. Rughetti, H. Rahimi, F. Agostini, V. Turchi, C. Apollonj Ghetti, G. Scambia, L. Frati, M. Nuti

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The humoral immune response to the polymorphic epithelial mucin (PEM) was studied by characterising the reactivity of human antibodies generated by EBV-immortalised B-cells from tumour-draining lymph nodes of ovarian cancer patients. All the human antibodies, selected in ELISA for their reactivity to the protein core tandem repeat sequence, reacted with PEM-expressing tumour cells. Aberrant glycosylation of the peptide core of the PEM molecule in cancer cells leads to the exposure of peptide epitopes that can be considered tumour specific. The epitope mapping of six human antibodies revealed that only one of them contained the PDTR sequence, shown to be the immunodominant epitope in the mouse. Four of the six human antibodies recognised a novel common immunogenic sequence (APPAH) in the tandem repeats. The binding of these human antibodies did not appear to be modulated by the length of the carbohydrate side chains, as shown by O-glycosylation inhibition studies. These results indicate that distinct sequences within the tandem repeat of PEM are target for a humoral immune response in humans. The presence of antibodies directed against different epitopes within the same antigenic region may modulate the antigen presentation process and the ongoing immune response. These data may help in clarifying the mechanisms of the immune response to PEM in cancer patients for the development of PEM-based immunotherapy.

Original languageEnglish
Pages (from-to)2155-2163
Number of pages9
JournalEuropean Journal of Cancer
Volume32
Issue number12
DOIs
Publication statusPublished - Nov 1996

Fingerprint

Mucin-1
Tandem Repeat Sequences
Ovarian Neoplasms
Antibodies
Neoplasms
Humoral Immunity
Glycosylation
Epitopes
Epitope Mapping
Immunodominant Epitopes
Peptides
Antigen Presentation
Human Herpesvirus 4
Immunotherapy
B-Lymphocytes
Lymph Nodes
Enzyme-Linked Immunosorbent Assay
Carbohydrates
Proteins

Keywords

  • epitope mapping
  • human antibodies
  • immune response
  • polymorphic epithelial mucin
  • tumour-associated antigens

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Human antibodies against the polymorphic epithelial mucin in ovarian cancer patients recognise a novel sequence in the tandem repeat region. / Petrarca, C.; Rughetti, A.; Rahimi, H.; Agostini, F.; Turchi, V.; Ghetti, C. Apollonj; Scambia, G.; Frati, L.; Nuti, M.

In: European Journal of Cancer, Vol. 32, No. 12, 11.1996, p. 2155-2163.

Research output: Contribution to journalArticle

Petrarca, C. ; Rughetti, A. ; Rahimi, H. ; Agostini, F. ; Turchi, V. ; Ghetti, C. Apollonj ; Scambia, G. ; Frati, L. ; Nuti, M. / Human antibodies against the polymorphic epithelial mucin in ovarian cancer patients recognise a novel sequence in the tandem repeat region. In: European Journal of Cancer. 1996 ; Vol. 32, No. 12. pp. 2155-2163.
@article{e37cae1e5a954b4697b41549003e1021,
title = "Human antibodies against the polymorphic epithelial mucin in ovarian cancer patients recognise a novel sequence in the tandem repeat region",
abstract = "The humoral immune response to the polymorphic epithelial mucin (PEM) was studied by characterising the reactivity of human antibodies generated by EBV-immortalised B-cells from tumour-draining lymph nodes of ovarian cancer patients. All the human antibodies, selected in ELISA for their reactivity to the protein core tandem repeat sequence, reacted with PEM-expressing tumour cells. Aberrant glycosylation of the peptide core of the PEM molecule in cancer cells leads to the exposure of peptide epitopes that can be considered tumour specific. The epitope mapping of six human antibodies revealed that only one of them contained the PDTR sequence, shown to be the immunodominant epitope in the mouse. Four of the six human antibodies recognised a novel common immunogenic sequence (APPAH) in the tandem repeats. The binding of these human antibodies did not appear to be modulated by the length of the carbohydrate side chains, as shown by O-glycosylation inhibition studies. These results indicate that distinct sequences within the tandem repeat of PEM are target for a humoral immune response in humans. The presence of antibodies directed against different epitopes within the same antigenic region may modulate the antigen presentation process and the ongoing immune response. These data may help in clarifying the mechanisms of the immune response to PEM in cancer patients for the development of PEM-based immunotherapy.",
keywords = "epitope mapping, human antibodies, immune response, polymorphic epithelial mucin, tumour-associated antigens",
author = "C. Petrarca and A. Rughetti and H. Rahimi and F. Agostini and V. Turchi and Ghetti, {C. Apollonj} and G. Scambia and L. Frati and M. Nuti",
year = "1996",
month = "11",
doi = "10.1016/S0959-8049(96)00254-7",
language = "English",
volume = "32",
pages = "2155--2163",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "12",

}

TY - JOUR

T1 - Human antibodies against the polymorphic epithelial mucin in ovarian cancer patients recognise a novel sequence in the tandem repeat region

AU - Petrarca, C.

AU - Rughetti, A.

AU - Rahimi, H.

AU - Agostini, F.

AU - Turchi, V.

AU - Ghetti, C. Apollonj

AU - Scambia, G.

AU - Frati, L.

AU - Nuti, M.

PY - 1996/11

Y1 - 1996/11

N2 - The humoral immune response to the polymorphic epithelial mucin (PEM) was studied by characterising the reactivity of human antibodies generated by EBV-immortalised B-cells from tumour-draining lymph nodes of ovarian cancer patients. All the human antibodies, selected in ELISA for their reactivity to the protein core tandem repeat sequence, reacted with PEM-expressing tumour cells. Aberrant glycosylation of the peptide core of the PEM molecule in cancer cells leads to the exposure of peptide epitopes that can be considered tumour specific. The epitope mapping of six human antibodies revealed that only one of them contained the PDTR sequence, shown to be the immunodominant epitope in the mouse. Four of the six human antibodies recognised a novel common immunogenic sequence (APPAH) in the tandem repeats. The binding of these human antibodies did not appear to be modulated by the length of the carbohydrate side chains, as shown by O-glycosylation inhibition studies. These results indicate that distinct sequences within the tandem repeat of PEM are target for a humoral immune response in humans. The presence of antibodies directed against different epitopes within the same antigenic region may modulate the antigen presentation process and the ongoing immune response. These data may help in clarifying the mechanisms of the immune response to PEM in cancer patients for the development of PEM-based immunotherapy.

AB - The humoral immune response to the polymorphic epithelial mucin (PEM) was studied by characterising the reactivity of human antibodies generated by EBV-immortalised B-cells from tumour-draining lymph nodes of ovarian cancer patients. All the human antibodies, selected in ELISA for their reactivity to the protein core tandem repeat sequence, reacted with PEM-expressing tumour cells. Aberrant glycosylation of the peptide core of the PEM molecule in cancer cells leads to the exposure of peptide epitopes that can be considered tumour specific. The epitope mapping of six human antibodies revealed that only one of them contained the PDTR sequence, shown to be the immunodominant epitope in the mouse. Four of the six human antibodies recognised a novel common immunogenic sequence (APPAH) in the tandem repeats. The binding of these human antibodies did not appear to be modulated by the length of the carbohydrate side chains, as shown by O-glycosylation inhibition studies. These results indicate that distinct sequences within the tandem repeat of PEM are target for a humoral immune response in humans. The presence of antibodies directed against different epitopes within the same antigenic region may modulate the antigen presentation process and the ongoing immune response. These data may help in clarifying the mechanisms of the immune response to PEM in cancer patients for the development of PEM-based immunotherapy.

KW - epitope mapping

KW - human antibodies

KW - immune response

KW - polymorphic epithelial mucin

KW - tumour-associated antigens

UR - http://www.scopus.com/inward/record.url?scp=0030298428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030298428&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(96)00254-7

DO - 10.1016/S0959-8049(96)00254-7

M3 - Article

VL - 32

SP - 2155

EP - 2163

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 12

ER -